Skip to content

Prednimustine

Alkylating Drug — ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS

Also known as: prednisolone chlorambucil ester, sterecyt, stereocyt

OfpATC L01AA08

Data last refreshed: (DrugCentral release 2024-11-01)

Key facts

Prednimustine is an ofp drug in the Alkylating Drug class catalogued in DrugCentral. Its mechanism of action is classified as Alkylating Activity and Corticosteroid Hormone Receptor Agonists.

  • Approval status: ofp.
  • Drug class: Alkylating Drug; Corticosteroid.
  • Mechanism of action: Alkylating Activity; Corticosteroid Hormone Receptor Agonists.
  • ATC code: L01AA08 (Nitrogen mustard analogues).
  • Molecular formula: C35H45Cl2NO6; molecular weight 646.65 g/mol.

Mechanism & targets

Mechanism of action (MoA)Alkylating Activity; Corticosteroid Hormone Receptor Agonists
Established pharmacologic classAlkylating Drug; Corticosteroid

ATC classification

ATC codeTherapeutic hierarchy
L01AA08ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS › ANTINEOPLASTIC AGENTS › ALKYLATING AGENTS › Nitrogen mustard analogues

Chemical structure

Full physicochemical, ADMET and 3D-structure analysis of Prednimustine is on its molecule page.

Molecular formulaC35H45Cl2NO6
Molecular weight646.65 g/mol
CAS number—
InChIKeyHFVNWDWLWUCIHC-GUPDPFMOSA-N
PubChem CID2708
C[C@]12C[C@H](O)[C@H]3[C@@H](CCC4=CC(=O)C=C[C@]34C)[C@@H]1CC[C@]2(O)C(=O)COC(=O)CCCC1=CC=C(C=C1)N(CCCl)CCCl

Frequently asked questions

Answers are generated from the structured data on this page, not written by hand.

How does Prednimustine work?

Prednimustine is classified as Alkylating Activity and Corticosteroid Hormone Receptor Agonists.

What drug class does Prednimustine belong to?

Prednimustine is in the Alkylating Drug class.

What is the chemical formula of Prednimustine?

Prednimustine has the molecular formula C35H45Cl2NO6 and a molecular weight of 646.65 g/mol.

Browse: all drugs starting with P · drug guides by category · protein targets A–Z.

Sources

How this page is built: methodology · editorial policy & corrections.

For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.

Quick facts

StatusOFP
First approval—
Agency—
Targets0
Indications0
FormulaC35H45Cl2NO6
DrugCentral ID2244
Interactive profile